Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide Webcast (2023)

(1:44:32)

Strategies for Managing VEGF-TKI Toxicities

(4:59)

Managing toxicities associated with CAR-T therapies

(7:19)

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

(1:42:46)

Managing toxicities associated with immune-checkpoint inhibitors

(14:42)

Dr. Martins on Managing Toxicities Associated With Lenvatinib in DTC

(59)

Dr. Kumar on Managing Toxicities in the MLN9708 Study

(39)

Dr. Apolo on Managing Toxicities of Checkpoint Inhibitors in Bladder Cancer

(1:32)

Managing Pre-Eclampsia \u0026 Eclampsia: High-Risk Pregnancy Care

(56:9)

Dr. Sznol on Managing Toxicities in Treatment of Melanoma

(1:1econd)

Dose Escalation \u0026 Managing Toxicities of Neratinib

(6:4)

Managing Toxicities Associated With Regorafenib

(11:24)

Managing toxicities associated with immunotherapy in multiple myeloma

(1:29)

Managing Toxicities and Access in Follicular Lymphoma Care

(5:22)

Managing Toxicities Of Moxetumomab Pasudotox

(1:4)

Managing Toxicities with Sorafenib in HCC

(4:6)

Management of Toxicities in an Outpatient Setting with Krista Rubin, MS, FNP-BC

(47:6)

How to manage toxicities from Immune Checkpoint Inhibitors?

(7:25)

Education Session: Toxicity Management - Next Gen Therapies Means Next Gen Toxicities

(1:57:50)

Toxicity Management in Advanced Renal Cell Carcinoma: Immunotherapy Insights

(42:36)